Apr 2025 $6 M No. 5 $2 to $10 million 9
OncoResponse Inc: Raise no. 5, Apr 2025 × Investors in this round 9 investors had bought by the notice of May 6, 2025: 9 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $6 M (amount offered: indefinite)
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Alice J. Bexon · Executive Officer Chris D. Russell · Executive Officer Clifford J. Stocks · Director, Executive Officer Kamal D. Puri · Executive Officer Carol D. Gallagher · Director John A. McKearn · Director Roberto D. De Ponti · Director Sean A. McCarthy · Director Steven D. Gillis · Director Wende D. Hutton · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Clifford J. Stocks, Chief Executive Officer. Source: SEC Form D, newest notice filed May 6, 2025. Read the notice at the SEC .
equity, options SEC May 2023 $14 M No. 4 $10 to $50 million 13
OncoResponse Inc: Raise no. 4, May 2023 × Investors in this round 13 investors had bought by the notice of May 12, 2023: 13 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $14 M of $40 M offered; $26 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people $4,800,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Christopher A. Russell · Executive Officer Clifford J. Stocks · Executive Officer, Director Kamal D. Puri · Executive Officer Robert J. Lechleider · Executive Officer John A. McKearn · Director Roberto A. DePonti · Director Sean A. McCarthy · Director Steven A. Gillis · Director Ted A. Koutouzis · Director Wende A. Hutton · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “The amount reflects payment of accrued and unpaid bonuses from periods prior to the offering and anticipated salary to the listed executive officers and potential bonus payments for the following 24-month period.”Signed by Clifford J. Stocks, Chief Executive Officer. Source: SEC Form D, newest notice filed May 12, 2023. Read the notice at the SEC .
equity SEC Mar 2021 $41 M No. 3 $10 to $50 million 14
OncoResponse Inc: Raise no. 3, Mar 2021 × Investors in this round 14 investors had bought by the notice of Mar 31, 2021: 14 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $41 M of $60 M offered; $19 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people $1,400,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Bob Joseph Lechleider · Executive Officer Clifford Stocks · Executive Officer, Director Kamal Joseph Puri · Executive Officer Daguang Joseph Wang · Director John McKearn · Director Patrick Joseph Hojlo · Director Roberto DePonti · Director Steven Gillis · Director Ted Koutouzis · Director Wende Hutton · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “The amount reflects payment of accrued and unpaid bonuses from periods prior to the offering and anticipated salary to the listed executive officers and potential bonus payments for the following 24-month period.”Signed by Clifford J. Stocks, Chief Executive Officer. Source: SEC Form D, newest notice filed Mar 31, 2021. Read the notice at the SEC .
equity SEC Aug 2018 $19 M No. 2 $10 to $50 million 12
OncoResponse Inc: Raise no. 2, Aug 2018 × Investors in this round 12 investors had bought by the notice of Sep 6, 2018: 12 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $19 M of $40 M offered; $21 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people $1,200,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Clifford Stocks · Executive Officer, Director Andrew Perlman · Director John McKearn · Director Nathan Jorgensen · Director Roberto DePonti · Director Steven Gillis · Director Wende Hutton · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “The amount reflects payments of accrued and unpaid bonuses from periods prior to the offering and anticipated salary to the listed executive officers and potential bonus payments for the following 24-month period.”Signed by Clifford J. Stocks, Chief Executive Officer. Source: SEC Form D, newest notice filed Sep 6, 2018. Read the notice at the SEC .
equity SEC Sep 2015 $30 M No. 1 $10 to $50 million 12
OncoResponse Inc: Raise no. 1, Sep 2015 × Investors in this round 12 investors had bought by the notice of Mar 23, 2017: 12 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $30 M of $34 M offered; $5 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Clifford Stocks · Executive Officer, Director Russ Hawkinson · Executive Officer Alan Ginsberg · Director Andrew Perlman · Director Roberto De Ponti · Director Steve Gillis · Director Wende Hutton · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Russ Hawkinson, Chief Financial Officer. Source: SEC Form D and 2 amendments, newest notice filed Mar 23, 2017. Read the notice at the SEC .
equity SEC